Skip to content

CB Pharma

Active Risk: not assessed Private limited companyfounded 2026active for less than a yearZandstraat 42, 2470 RetieKBO/BCE: BE 1041.228.088
CB Pharma
Follow ReportCompare

Board

1 director, since incorporation
BELMANS Carmen Dirk Leonarda
Director
since 12-08-2026 term without a fixed end
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Het bestuursorgaan vertegenwoordigt de vennootschap jegens derden, met inbegrip van de vertegenwoordiging in rechte. Indien er verschillende…”
deed of 14-08-2026

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
BELMANS Carmen Dirk Leonarda
Director
Board
Mandates as a list
  • BELMANS Carmen Dirk Leonarda
    • Director, from 12-08-2026 to date

Control

Founder
BELMANS Carmen Dirk Leonarda
This company
CB Pharma

Capital

Contribution
€5,000
Source
deed of 14-08-2026

Articles of association

deed of 14-08-2026 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
“Tenzij de algemene vergadering bij hun benoeming anders beslist, worden de bestuurders onbezoldigd voor de uitoefening van hun mandaat.”
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Friday of June at 20:00

Shareholders

At incorporation deed of 14-08-2026 ↗

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure